Arizona Tribune - Boulevard

Trustpoint Xposure Analysis Reveals How AI Tools Are Selecting One Company Instead of Many

Why AI Answer Engines Are Replacing Comparison With Elimination in Competitive Search

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, CA / ACCESS Newswire / January 12, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, today announced that on January 8, 2026, the Compensation Committee of Revelation's Board of Directors approved an inducement grant consisting of 90,000 restricted stock units ("RSUs") covering 90,000 shares of the Company's common stock to a new non-executive employee. The RSUs were granted outside of the Company's stockholder-approved equity incentive plan. The award was granted as an inducement material to the employee's acceptance of employment with Revelation in accordance with Nasdaq Listing Rule 5635(c)(4).

Trustpoint Xposure is The Only AEO-Certified Agency Designed for AI- First Search.

As AI-powered search reshapes how people discover brands, Trustpoint Xposure is outlining why it operates as the only AEO-certified agency intentionally built for AI-first search, rather than adapted from traditional SEO or public relations models.

Trustpoint Xposure Sets Industry Standard as The Only AEO-certified PR Agency for AI Search

Trustpoint Xposure today announced its position as an AEO-certified PR agency, setting a new industry standard for how brands earn visibility, credibility, and citations in AI-powered search environments.

Jorie AI Introduces Clinically Driven Predictive Analytics to Support Proactive Care and Revenue Performance

Hospital-specific predictive analytics designed to identify risk earlier, improve outcomes, and significantly reduce costs

GridAI and the Financial Mechanics of Grid Intelligence

BOCA RATON, FL / ACCESS Newswire / January 12, 2026 / Grid intelligence only matters if it changes cost structures, creates new revenue streams, or both. Otherwise, it's just another layer of software observing problems it can't influence. The reason grid orchestration, and the companies providing it, have moved from theoretical discussion to an investable category is straightforward. The dollars involved are no longer marginal. They are large, recurring, and increasingly unavoidable.

Medical Care Technologies Inc. (OTC PINK:MDCE) 2026 Annual Shareholder Update and Strategic Roadmap

MESA, AZ / ACCESS Newswire / January 12, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology-focused company developing AI-driven consumer, wellness, and medical applications, today provided its 2026 annual shareholder update outlining its short-term, near-term, and long-term strategic goals as the Company advances its next phase of growth. These updates are also updated on our corporate website www.medicalcaretechnologies.com.

MDaudit Recognized as One of Modern Healthcare's Best in Business

WELLESLEY, MA / ACCESS Newswire / January 12, 2026 / MDaudit, an award-winning cloud-based continuous risk monitoring platform for healthcare revenue cycle management, is honored to be recognized by Modern Healthcare as one of the Best in Business of 2025. The annual program celebrates organizations that drive innovation, efficiency, and excellence, highlighting their pivotal role in enhancing the overall healthcare ecosystem.

Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity

Company demonstrates commercial-scale production of its Toll-like Receptor 5 (TLR5) agonist for Acute Radiation Syndrome (ARS) and Neutropenia through wholly owned contract development manufacturing organization (CDMO), Velocity BioworksCompany's next step is to initiate production under current Good Manufacturing Practice (cGMP), a critical milestone moving towards filing a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA)Milestone achieved in advance of January 26 TechWatch meeting with the Biomedical Advance Research and Development Authority (BARDA) to discuss federal strategic relevance of Entolimod™ for ARS

US Med-Equip Recognized as One of Modern Healthcare's Best in Business

Fast-Growing Rental Company Honored for Supply Chain Excellence Supporting Hospitals

Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million

$18M upfront payment to Jaguar ($16M upon deal closing and $2M upon completion of post-closing conditions)Up to additional $20M in milestone and other future paymentsFuture Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1Jaguar continues to be the manufacturer of Mytesi and Canalevia-CA1Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD discussions with other potential partners

CASI Pharmaceuticals Announces Update and Additional Results from Phase 1 Study of CID-103 in Adult Patients with Chronic Immune Thrombocytopenia

Additional proof of concept data consistent and strengthen data set shared at ASH 2025Management to host meetings at JP Morgan 44th Annual Healthcare Conference 2026

VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital

VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability

GridAI: The Grid Is the New Battleground for AI Economics

BOCA RATON, FL / ACCESS Newswire / January 12, 2026 / For years, investors were trained to believe the bottleneck in artificial intelligence would be chips. Then it was talent. Then it was data. Each time, the market adjusted, capital flowed, and new winners emerged. What has changed quietly, but decisively, is where that constraint now lives.

Ozempic Face and Loose Skin Surge Drives DMV Patients to The Naderi Center's Advanced Non-Surgical & Surgical Treatments

Experts emphasize individualized care as demand grows for solutions to facial volume loss and loose skin following medical weight reduction.

Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided additional details for its upcoming Investor Day, scheduled for Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City. The Investor Day will be both in-person and available to view via webcast.

OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine

Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference

Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings CallImproves 2025 expected GAAP operating expenses by $200 million since 3Q25 Earnings CallIncreases 2025 projected year-end cash balance to approximately $8.1 billion (unaudited)Reiterates plan to deliver up to 10% revenue growth and GAAP operating expense reductions in 2026Anticipates potential first approvals of flu and flu/COVID combination products in 2026Expects pivotal trial data readouts in oncology, rare disease and infectious disease in 2026

Black Book Research Releases 2026 State of South Korean Acute Care EMR Digital Adoption Report

Strategic Fit Assessment Finds Leadership Concentrated in Enterprise-Scale Clinical Performance and Resilience While Cloud Agility, Partnership Value, and Patient Engagement Create New "Wedge" Opportunities

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug development and clinical oncology, is pleased to announce that further to the announcement of 15 December 2025, that the following have been appointed to the board with immediate effect:

Wildfires spread to 15,000 hectares in Argentine Patagonia

Forest fires in southern Argentina have scorched more than 15,000 hectares (37,000 acres) this week, authorities said, though rain began falling in parts of Patagonia on Sunday to the relief of residents.

AI pendants back in vogue at tech show after early setback

Pendants and brooches packed with artificial intelligence abounded at the Consumer Electronics show, using cameras and microphones to watch and listen through the day like a vigilant personal assistant.

Rallies across US after woman shot and killed by immigration agent

Thousands of demonstrators took to the streets of Minneapolis on Saturday chanting the name of the woman killed by a federal agent in the city, amid widespread anger at use of force in the Trump administration's immigration crackdown.

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward "AI That Ships," Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes) and renewed appetite for carve-outs, milestone bridges, and structured financings heading into JPM Week 2026 from Black Book Research flash polls.

Argentina wildfire burns over 5,500 hectares: governor

A major forest fire in southern Argentina has burned more than 5,500 hectares, authorities said Saturday, as hundreds of firefighters and volunteers battled to contain the blaze threatening small communities.

Benin showcases culture with Vodun Days

On the newly-renovated streets of Ouidah, thousands of Beninese and foreign tourists gathered this week to discover the rituals and deities bound up with voodoo, a popular animist tradition which has grown to become the focus of a international festival.

New rallies erupt in Iran as crackdown fears grow

Major Iranian cities were gripped overnight by new mass rallies denouncing the Islamic republic, as activists on Saturday expressed fear authorities were intensifying their suppression of the demonstrations under cover of an internet blackout.

'Racing against time': Death toll rises after Philippines trash site collapse

Hard hat-wearing rescue workers and backhoes dug through rubble in search of survivors on Saturday in the shadow of a mountain of garbage that buried dozens of landfill employees in the central Philippines, killing at least six.

New rallies in Iran as son of shah calls for city centres to be seized

Major Iranian cities were gripped overnight by new mass rallies denouncing the Islamic republic, as the son of the ousted shah urged protesters on Saturday to plan to seize city centres.

Neighbors in Minneapolis protect each other from US immigration police

When Jennifer Arnold learned one of her neighbors in the midwestern city of Minneapolis had been arrested by immigration authorities late last year, she reached out to lend a hand.

Death toll climbs after trash site collapse buries dozens in Philippines

Hard hat-wearing rescue workers and backhoes dug through rubble in search of survivors on Saturday in the shadow of a mountain of garbage that buried dozens of landfill employees in the central Philippines, killing at least four.

RBGPF	1.65%	83.78	$
SCS	0.12%	16.14	$
CMSD	-0.17%	24.05	$
RELX	-1.03%	35.8	$
AZN	0.19%	92.77	$
CMSC	0.21%	23.76	$
NGG	0.23%	85.27	$
BCE	1.43%	25.86	$
BTI	0.76%	60.68	$
BP	-0.42%	37.88	$
RIO	-4.5%	91.03	$
BCC	0.63%	80.81	$
VOD	-0.41%	14.65	$
GSK	1.82%	51.6	$
RYCEF	-2.69%	16	$
JRI	1.07%	13.08	$

Arizona Tribune - Boulevard (English)

Featured

Venezuelan interim president announces mass amnesty push

Venezuelan interim president proposes mass amnesty law

Last news